Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (391-400 of 715) with videos related to

Pageof 72
Sort By:
The Journal of Biological Chemistry|June 15, 1992
Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activatorP J Declerck, M De Mol, D E Vaughan, et al.
Blood|July 1, 1991
Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism modelH R Lu, H R Lijnen, J M Stassen, et al.
The Journal of Biological Chemistry|January 15, 1991
Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activatorK Bartha, P J Declerck, H Moreau, et al.
Drugs|September 1, 1989
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agentD Collen, H R Lijnen, P A Todd, et al.
The Journal of Clinical Investigation|August 1, 1989
Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbitsD E Vaughan, P J Declerck, M De Mol, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1982
In vivo studies of a synthetic inhibitor of thrombinD Collen, O Matsuo, J M Stassen, et al.
The Journal of Biological Chemistry|December 15, 1988
Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, B Van Hoef, et al.
The Journal of Clinical Investigation|June 1, 1995
Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic diseaseP Holvoet, G Perez, Z Zhao, et al.
The Journal of Biological Chemistry|January 25, 1986
Activation of plasminogen by pro-urokinase. I. MechanismH R Lijnen, C Zamarron, M Blaber, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in miceN Nagai, Y Suzuki, B Van Hoef, et al.
Pageof 72

Showing results (391-400 of 715) with videos related to

Sort By:
Pageof 72
The Journal of Biological Chemistry|June 15, 1992
Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activatorP J Declerck, M De Mol, D E Vaughan, et al.
Blood|July 1, 1991
Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism modelH R Lu, H R Lijnen, J M Stassen, et al.
The Journal of Biological Chemistry|January 15, 1991
Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activatorK Bartha, P J Declerck, H Moreau, et al.
Drugs|September 1, 1989
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agentD Collen, H R Lijnen, P A Todd, et al.
The Journal of Clinical Investigation|August 1, 1989
Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbitsD E Vaughan, P J Declerck, M De Mol, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1982
In vivo studies of a synthetic inhibitor of thrombinD Collen, O Matsuo, J M Stassen, et al.
The Journal of Biological Chemistry|December 15, 1988
Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, B Van Hoef, et al.
The Journal of Clinical Investigation|June 1, 1995
Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic diseaseP Holvoet, G Perez, Z Zhao, et al.
The Journal of Biological Chemistry|January 25, 1986
Activation of plasminogen by pro-urokinase. I. MechanismH R Lijnen, C Zamarron, M Blaber, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in miceN Nagai, Y Suzuki, B Van Hoef, et al.
Pageof 72